SAC Capital Takes 6.5% Stake In Genoptix (GXDX)

SAC Capital Takes 6.5% Stake In Genoptix GXDX, disclosed in 13G SEC filing.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!